GRDN — Guardian Pharmacy Services, Inc. Stock Price, Chart & AI Report

Negative Mar 19, 2026 • 12:41 UTC Benzinga • Rishabh Mishra

Stock Market Today: S&P 500, Dow Jones Futures Slip As Jobless Claims Fall To 205,000— Micron, FedEx, Constellation Energy In Focus (UPDATED)

U.S. stock futures declined on Thursday as markets processed the Federal Reserve's decision to maintain interest rates at 3.50%-3.75%. Geopolitical tensions escalated as President Trump warned Iran against strikes on Qatar's LNG facilities. Key stocks in focus include Micron Technology, FedEx, Constellation Energy, and Guardian Pharmacy Services, with mixed performance across sectors.

MU FDX CEG GRDN stock market S&P 500 Dow Jones Federal Reserve

Sentiment note

Stock dropped 10.06% after announcing a proposed public offering of 5 million shares, indicating significant shareholder dilution concerns.

Positive Nov 13, 2025 • 21:37 UTC Investing.com • Ryan Hasson

Guardian Pharmacy Services Breakout Raises Questions on Strength of Q3 Momentum

Guardian Pharmacy Services reported strong Q3 earnings, exceeding analyst expectations with $377 million revenue and raised full-year guidance, signaling potential growth in long-term care pharmacy services.

GRDN pharmacy services healthcare long-term care earnings guidance

Sentiment note

Exceeded quarterly earnings estimates, raised full-year guidance, increased revenue by 20% year-over-year, expanded resident service by 13%, and showed growing institutional investor interest

Positive Nov 11, 2025 • 20:24 UTC The Motley Fool • Eric Volkman

Why Guardian Pharmacy Services Stock Was on a Tear Tuesday

Guardian Pharmacy Services reported strong Q3 performance with 20% revenue growth and raised full-year guidance, driving stock price up nearly 5%.

GRDN healthcare pharmacy services quarterly earnings revenue growth

Sentiment note

Company exceeded analyst revenue expectations, increased total residents served by 13%, raised full-year revenue and EBITDA guidance, and demonstrated strong financial performance in only its second year post-IPO